渴络欣联合依那普利治疗糖尿病肾病的临床研究

目的: 观察渴络欣联合依那普利治疗糖尿病肾病(DN)的临床疗效。方法: 早期糖尿病肾病(DN Ⅲ期)患者43例和临床糖尿病肾病(DN Ⅳ期)37例分别随机分为依那普利对照组和渴络欣联合依那普利治疗组,疗程均为2个月。结果: 与治疗前比较,治疗组治疗后血清总胆固醇(TC)、血清甘油三酯(TG)、血清低密度脂蛋白胆固醇(LDL-C)明显下降(P<0.05,P<0.01),血清高密度脂蛋白胆固醇(HDL-C)明显上升(P<0.05),对照组上述指标变化无统计学意义(P>0.05)。治疗后治疗组和对照组早期DN患者尿白蛋白排泄率(UAER)、尿α₁微球蛋白(α₁-MG)、尿β₂微球蛋白(β₂-MG)均明显减少(P<0.05,P<0.01),而治疗组较对照组疗效更为显著(P<0.05)。对临床DN患者的尿蛋白定量、尿α₁-MG、尿β₂-MG、血白蛋白(ALB),治疗组和对照组均改善显著(P<0.05,P<0.01),但治疗组优于对照组(P<0.05);对临床DN患者的血肌酐(Cr),对照组无明显改善(P>0.05),但治疗组却改善显著(P<0.05)。结论: 渴络欣联合依那普利治疗DN疗效肯定,在减少尿蛋白、改善肾功能方面明显优干单用依那普利,提示两药合用在延缓DN进展方面能够发挥各自的优势,起到协同作用。

Cinical study of Keluoxin combined with enalapril in treatment of diabetic nephropathy

AIM: To study the clinical curative effect of keluoxin collocystis combined with enalapril in treatment of diabetic nephropathy.METHODS: Forty three patients with early diabetic nephropathy and 37 patients with clinical diabetic nephropathy were randomly divided into enalapril control group and keluoxin combined with enalapril treated group,the tota1 course of treatment was 2 months.RESULTS: After 2 months of treatment,the levels of TC,TG and LDL-C in treated group were decreased obviously (P<0.05,P<0.01),the level of HDL-C was elevated obviously (P<0.05)in treated group,while there were no significant difference of TG, TC, LDL-C and HDL-C in control group.The UAER, α₁-MG、β₂-MG were decreased significantly in both groups in early diabetic nephropathy(P<0.05,P<0.01),but more significant in treated group than that in control group (P<0.05).The urine protein quantitative, urinaryα₁-MG, urinaryβ₂-MG and blood albumin were improved significantly in both groups in clinical diabetic nephropathy(P<0.05,P<0.01),but more significant in treated group than that in control group (P<0.05);the serum creatinine (Scr) in the clinical DN patients of control group was no obvious improvement (P>0.05),but the Scr in treatment group was improved significantly (P<0.05).CONCLUSION: Keluoxin combined with enalapril in treatment of DN patients has better effectiveness in reducing albuminuria and in improving renal function than enalapril alone.The data indicates that the combination of the two drugs can help each other against DN development. Keluoxin combined with enalapril are effective in treatment of diabetic nephropathy.